Treatment of bone metastatic pain with SM153-EDTMP. Evaluation of the analgesic response and the existence of differences according to the primary tumor and the metastatic pattern;Tratamiento del dolor óseo metastásico con Sm 153-EDTMP. Valoración de la respuesta analgésica y de la existencia de diferencias según el tipo de tumor y el patrón metastásico

Revista Espanola de Medicina Nuclear

Volumn 24, Issue 5, 2005, Pages 297-304

  Ubieto, M A ^a   Abos M D ^a   Tardin, A L ^a   Razola, P ^a   Prats, E ^a   Garcia F ^a   Polo, E ^a   Yubero, A ^b   Banzo, J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL OBISPO POLANCO   (Spain)

Author keywords

Bone metastases; Metastatic bone pain; Radiometabolic therapy; Sm153 EDTMP

Indexed keywords

LEXIDRONAM SAMARIUM SM 153; TECHNETIUM 99M;

ARTICLE; BONE METASTASIS; BONE PAIN; BONE SCINTISCANNING; BREAST CANCER; CANCER PAIN; CLINICAL ARTICLE; FEMALE; HUMAN; INTESTINE CANCER; LUNG CANCER; MALE; PROSTATE CANCER; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUMOR;

EID: 28444485668     PISSN: 02126982     EISSN: None     Source Type: Journal    
DOI: 10.1157/13079280     Document Type: Article

References (23)

1. Serafini AN. Therapy of metastatic bone pain. J Nucl Med. 2001;42:895-906.
2. Coleman RE. Management of bone metastases. Oncologist. 2000;5:463-70.
3. Morris MJ, Scher HI. Clinical approaches to osseous metastases in prostate cancer. Oncologist. 2003;8:161-73.
4. World Health Organization. Cancer pain relief and palliative care: report of a WHO expert committee. Geneva, Switzerland: World Health Organization; 1990.
5. Pons F, Fuster D, Vidal-Sicart S. Tratamiento paliativo del dolor óseo metastásico. Rev Esp Med Nucl. 2003;22:429-38.
6. Li S, Liu J, Zhang H, Tian M, Wang J, Zheng X. Rhenium-188 HEDP to treat painful bone metastases. Clin Nucl Med. 2001;26:919-22.
7. Goeckeler WF, Edwards B, Volkert WA, Holmes RA, Simon J, Wilson D. Skeletal localization of samarium-153 chelates: potential therapeutic bone agents. J Nucl Med. 1987;28:495-504.
8. Collins C, Eary JF, Donaldson G, Vernon C, Bush NE, Petersdorf S, et al. Samarium-153-EDTMP in bone metastases of hormone refractary prostate carcinoma: a phase I/II trial. J Nucl Med. 1993;34:1839-44.
9. Resche I, Chatal JF, Pecking A, Ell P, Duchesne G, Rubens R, et al. A dose-controlled study of 153 Sm-ethylenediaminetetramethylenephosphonate(EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer. 1997;33:1583-91.
10. Serafini AN, Houston SJ, Resche I, Quick DP, Grund FM, Ell PJ, et al. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol. 1998;16:1574-81.
11. Tian JH, Zhang JM, Hou QT, Oyang QH, Wang JM, Luan ZS, et al. Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate palliative treatment for painful metastases in China. Eur J Nucl Med. 1999;26:2-7.
12. Lovera C, Massardo T, Galleguillos MC, Gonzalez P, Comparini B, Yañez M, et al. Respuesta analgésica y efectos secundarios en pacientes con metastasis osteoblásticas, tratados con Samario 153 etilendiaminotetrametilenfosfato. Rev Med Chil. 1998;126:963-71.
13. Maini CL, Bergomi S, Romano L, Sciuto R. 153Sm-EDTMP for bone pain palliation in skeletal metastases. Eur J Nucl Med Mol Imaging. 2004;31 Suppl 1:S171-8.
14. Berna L, Martin F, Cunill C, Nadal C, Javier Mateos J, Ortega M, et al. 153Sm-EDTMP en un paciente afecto de cáncer de colon con metástasis ósea. Rev Esp Med Nucl. 2001;20:130-1.
15. Pons F, Herranz R, García A, Vidal-Sicart S, Conill C, Grau JJ, et al. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer. Eur J Nucl Med. 1997;24:1210-4.
16. Lam MG, de Kerk JM, van Rijk PP. 186Re-HEDP for metastatic bone pain in breast cancer patients. Eur J Nucl Med Mol Imaging. 2004;31 Suppl 1:S162-70.
17. Silberstein EB, Taylor AT Jr; EANM. EANM procedure guidelines for treatment of refractory metastatic bone pain. Eur J Nucl Med Mol Imaging. 2003;30:BP7-11.
18. Tian J, Cao L, Zhang J, Ouyang Q, Hou Q, He Y. Comparative analysis of patients not responding to a single dose of 153Sm-EDTMP palliative treatment for painful skeletal metastases. Chin Med J (Engl). 2002;115:824-8.
19. Li L, Liang Z, Deng H, Kuang A, Tan T, Luo S. Samarium-153-EDTMP bone uptake rate and its relation to therapeutic effect. Chin Med J (Engl). 2002;115:1096-8.
20. Menda Y, Bushnell DL, Williams RD, Miller S, Thomas MO. Efficacy and safety of repeated samarium-153 lexidronam treatment in a patient with prostate cancer and metastatic bone pain. Clin Nucl Med. 2000;25:698-700.
21. rd. Safety and efficacy of repeated sequential administrations of Re-186(Sn)HEDP as palliative therapy for painful skeletal metastases. Initial case reports of two patients. Clin Nucl Med. 1992;17:41-4.
22. Fuster D, Herranz R, Alcover J, Mateos JJ, Martin F, Vidal-Sicart S. Tratamiento del dolor óseo metastásico con dosis repetidas de estroncio-89 en pacientes con neoplasia prostática. Rev Esp Med Nucl. 2000;19:270-4.
23. Weiss K, Kock HH, Atefie K, Sinzinger H. Complete scintigraphic lesion regression after single 153Sm-EDTMP therapy in prostate cancer. Rev Esp Med Nucl. 2001;20:311-2.